# Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers

> **NCT00225667** · PHASE3 · UNKNOWN · sponsor: **Connolly, Stuart, M.D.** · enrollment: 200 (—)

## Conditions studied

- Atrial Fibrillation
- Hypertension

## Interventions

- **DRUG:** Irbesartan

## Key facts

- **NCT ID:** NCT00225667
- **Lead sponsor:** Connolly, Stuart, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2005-12
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 200 (—)
- **Last updated:** 2005-11-23

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00225667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00225667, "Irbesartan for the Prevention of Atrial Arrhythmias and Cardiac Electrical Remodeling in Patients With Hypertension and Permanent Pacemakers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00225667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*